Report
Olga Smolentseva ...
  • Thibaut Voglimacci-Stephanopoli

INVEST SECURITIES - VALBIOTIS: Valedia et le virage préventif du diabète de type 2

Underlying
Valbiotis SAS

Valbiotis SAS is a France-based company engaged in the biotechnology industry. The Company specializes in developing nutrition solutions designed to prevent cardiometabolic diseases and provide nutritional support for patients. It seeks to develop solutions designed to prevent type 2 diabetes, NASH, (non-alcoholic steatohepatitis) and obesity and to offer nutritional support. The Company prevents disease by developing products that reduce the risk factors of irreversible chronic diseases. It provides patient support through new-generation medical nutrition solutions containing patented substances with clinically proven effects. Its products are plant-based and undergo strict scientific and clinical tests in collaboration with academic research centers.

Provider
Invest Securities
Invest Securities

Since 2006, Invest Securities has become one of the leading players in investment services for funds and managers, to whom we offer a global and personalised service. Our track record differentiates us and proves our leadership in numerous promising sectors like property and growth companies.

Consisting of 13 different profiles (pharmacist, engineer, financier, etc), the DNA of our financial analysis office is value added and sector expertise. Through daily monitoring and detailed analyses of companies and sectors, we seek to provide a differentiating vision of our 120 stocks followed. Our ideas are circulated every day to nearly 1,000 professionals.

Analysts
Olga Smolentseva

Thibaut Voglimacci-Stephanopoli

Other Reports on these Companies
Other Reports from Invest Securities
Olga Smolentseva ...
  • Thibaut Voglimacci-Stephanopoli
Benoît Faure-Jarrosson ...
  • Bruno Duclos
  • Vladimir Minot
Other Reports from these Analysts

ResearchPool Subscriptions

Get the most out of your insights

Get in touch